CIBC Private Wealth Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $3.21M | Buy |
7,087
+289
| +4% | +$125K | 0.01% | 496 |
|
|
2025
Q3 | $2.66M | Sell |
6,798
-231
| -3% | -$96.5K | ﹤0.01% | 518 |
|
|
2025
Q2 | $3.13M | Buy |
7,029
+467
| +7% | +$215K | 0.01% | 491 |
|
|
2025
Q1 | $3.1M | Buy |
6,562
+508
| +8% | +$237K | 0.01% | 469 |
|
|
2024
Q4 | $2.49M | Sell |
6,054
-424
| -7% | -$197K | ﹤0.01% | 530 |
|
|
2024
Q3 | $3.01M | Sell |
6,478
-4,304
| -40% | -$2.07M | 0.01% | 503 |
|
|
2024
Q2 | $5.2M | Buy |
10,782
+8,003
| +288% | +$3.47M | 0.01% | 397 |
|
|
2024
Q1 | $1.17M | Sell |
2,779
-163
| -6% | -$68.9K | ﹤0.01% | 632 |
|
|
2023
Q4 | $1.2M | Sell |
2,942
-2,748
| -48% | -$1.02M | ﹤0.01% | 596 |
|
|
2023
Q3 | $1.98M | Buy |
5,690
+4,052
| +247% | +$1.42M | ﹤0.01% | 493 |
|
|
2023
Q2 | $576K | Buy |
1,638
+2
| +0.1% | +$674 | ﹤0.01% | 667 |
|
|
2023
Q1 | $515K | Sell |
1,636
-7,180
| -81% | -$2.15M | ﹤0.01% | 702 |
|
|
2022
Q4 | $2.55M | Buy |
8,816
+4,689
| +114% | +$1.43M | 0.01% | 389 |
|
|
2022
Q3 | $1.2M | Sell |
4,127
-5,049
| -55% | -$1.45M | ﹤0.01% | 558 |
|
|
2022
Q2 | $2.59M | Sell |
9,176
-12,348
| -57% | -$3.31M | 0.01% | 451 |
|
|
2022
Q1 | $5.62M | Buy |
21,524
+19,011
| +757% | +$4.51M | 0.01% | 385 |
|
|
2021
Q4 | $552K | Buy |
2,513
+21
| +0.8% | +$4.08K | ﹤0.01% | 753 |
|
|
2021
Q3 | $452K | Sell |
2,492
-32,524
| -93% | -$6.35M | ﹤0.01% | 745 |
|
|
2021
Q2 | $7.06M | Sell |
35,016
-2,412
| -6% | -$505K | 0.02% | 369 |
|
|
2021
Q1 | $8.04M | Buy |
37,428
+9,171
| +32% | +$2.01M | 0.02% | 352 |
|
|
2020
Q4 | $6.68M | Sell |
28,257
-172,320
| -86% | -$39.5M | 0.02% | 362 |
|
|
2020
Q3 | $54.6M | Buy |
+200,577
| New | +$55.3M | 0.17% | 122 |
|
|
2020
Q2 | – | Sell |
-161,997
| Closed | -$38.5M | – | 815 |
|
|
2020
Q1 | $38.5M | Buy |
161,997
+160,523
| +10,890% | +$36.8M | 0.17% | 123 |
|
|
2019
Q4 | $323K | Buy |
+1,474
| New | +$298K | ﹤0.01% | 788 |
|
|
2019
Q3 | – | Sell |
-2,495
| Closed | -$458K | – | 944 |
|
|
2019
Q2 | $458K | Buy |
+2,495
| New | +$436K | ﹤0.01% | 725 |
|
|
2018
Q4 | – | Sell |
-7,653
| Closed | -$1.48M | – | 965 |
|
|
2018
Q3 | $1.48M | Buy |
7,653
+7,199
| +1,586% | +$1.28M | 0.01% | 591 |
|
|
2018
Q2 | $77K | Sell |
454
-171
| -27% | -$26.5K | ﹤0.01% | 1081 |
|
|
2018
Q1 | $102K | Buy |
625
+243
| +64% | +$39.7K | ﹤0.01% | 1015 |
|
|
2017
Q4 | $57K | Sell |
382
-11,352
| -97% | -$1.68M | ﹤0.01% | 1151 |
|
|
2017
Q3 | $1.78M | Buy |
+11,734
| New | +$1.77M | 0.01% | 515 |
|
Other funds holding VRTX
CIBC Private Wealth Group's VRTX Position: Q4 2025 in Review
CIBC Private Wealth Group increased its Vertex Pharmaceuticals (VRTX) stake by 4.3% in Q4 2025, buying an estimated $125K and bringing the position to 7,087 shares worth $3.21M. The position accounts for 0.01% of the portfolio, ranked #496.
CIBC Private Wealth Group first reported a position in VRTX in Q3 2017 and has held it in 30 quarters since. The position peaked at $54.6M in Q3 2020. 1,669 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.
- CIBC Private Wealth Group held 7,087 shares of Vertex Pharmaceuticals worth $3.21M as of Q4 2025.
- CIBC Private Wealth Group bought 289 Vertex Pharmaceuticals shares in Q4 2025, an estimated $125K.
- Vertex Pharmaceuticals made up 0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #496 holding.
- CIBC Private Wealth Group first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 30 quarters since.
- CIBC Private Wealth Group's Vertex Pharmaceuticals position peaked at $54.6M in Q3 2020.
- 1,669 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.